Reviva Pharmaceuticals Holdings, Inc.

NASDAQ:RVPH

1.58 (USD) • At close January 14, 2025
Bedrijfsnaam Reviva Pharmaceuticals Holdings, Inc.
Symbool RVPH
Munteenheid USD
Prijs 1.58
Beurswaarde 73,595,136
Dividendpercentage 0%
52-weken bereik 0.6 - 4.83
Industrie Biotechnology
Sector Healthcare
CEO Dr. Laxminarayan Bhat Ph.D.
Website https://revivapharma.com

An error occurred while fetching data.

Over Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment

Vergelijkbare Aandelen

Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc.

MRKR

2.54 USD

Acurx Pharmaceuticals, Inc. logo

Acurx Pharmaceuticals, Inc.

ACXP

0.699 USD

Precipio, Inc. logo

Precipio, Inc.

PRPO

6.06 USD

Healthcare Triangle, Inc. logo

Healthcare Triangle, Inc.

HCTI

0.938 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)